Answers are grounded in this paper and cite their sources.
Citation Sun Y, Wang W, Shan B, Di J, Chen L, Ren L, Li W, Li D-J, Lin Y. FTY720-induced conversion of conventional Foxp3−CD4+ T cells to Foxp3+ regulatory T cells in NOD mice. Am J Reprod Immunol 2011; 66: 349–362 Problem FTY720 is known as an agonist of sphingosine-1-phosphate (S1P) receptor, but little is known about the possibility that FTY720 induces the conversion of conventional Foxp3−CD4+ T cells to Foxp3+ regulatory T cells in non-obese diabetic (NOD) mice. Method of study FTY720 treatment was performed using Foxp3−CD4+ T cells purified from NOD mice. Results FTY720 caused an increase in Foxp3+ Treg cells in lymphoid organs in NOD mice. FTY720 effectively induced Foxp3 expression in Foxp3−CD4+ T cells both in vitro and in vivo, an effect that was inhibited by a TGF-β-neutralizing antibody or the proinflammatory cytokine IL-6. T-cell-mediated embryo rejection in NOD mice was prevented upon FTY720 treatment. Conclusions The use of FTY720 along with Ag administration may represent a useful therapeutic strategy to selectively expand Ag-specific Foxp3+ Tregs to intervene autoimmune and infectious diseases.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: